Abstract
THIOUREA and derivatives1–3 and sulphonamide compounds4,5 inhibit the formation of the catabolic hormone both in normal and in hyperactive thyroids. In a vain attempt to compensate for the lack of hormone, the gland undergoes hyperplasia, and hypothyroidism with hyperplastic goitre can result1,6. A few isolated results suggest that the possibility of the drugs also antagonizing the circulating hormone cannot be excluded7.
Your institute does not have access to this article
Access options
Subscribe to Journal
Get full journal access for 1 year
$199.00
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Astwood, Sullivan, Bissell and Tyslowitz, Endocrin., 32, 210 (1943).
MacKenzie and MacKenzie, Endocrin., 32, 185 (1943).
Campbell, Landgrebe and Morgan, Lancet, i, 630 (1944).
Cutting and Kuzell, J. Pharmacol., 69, 37 (1940).
Astwood, J. Pharmacol., 78, 79 (1943).
Donald and Dunlop, Brit. Med. J., i, 117 (1945).
Martin, Arch. Biochem., 3, 61 (1943).
Glaubach and Pick, Arch. exp. Path. Pharmak., 162, 551 (1931).
Peczenik, Popper and Schmid, Confinia Neurol., 3, 331 (1941).
Chapman, Quart. J. Pharm. Pharmacol., 17, 314 (1944).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
PECZENIK, O. Action of Thyroxin and the Response of the Thyroid to Treatment with Sulpha Drugs. Nature 157, 771–772 (1946). https://doi.org/10.1038/157771b0
Issue Date:
DOI: https://doi.org/10.1038/157771b0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
